Literature DB >> 11169165

Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders.

L D Kong1, R X Tan, A Y Woo, C H Cheng.   

Abstract

Psoralen and isopsoralen, furocoumarins isolated from the plant Psoralea corylifolia L., were demonstrated to exhibit in vitro inhibitory actions on monoamine oxidase (MAO) activities in rat brain mitochondria, preferentially inhibiting MAO-A activity over MAO-B activity. This inhibition of enzyme activities was found to be dose-dependent and reversible. For MAO-A, the IC50 values are 15.2 +/- 1.3 microM psoralen and 9.0 +/- 0.6 microM isopsoralen. For MAO-B, the IC50 values are 61.8 +/- 4.3 microM psoralen and 12.8 +/- 0.5 microM isopsoralen. Lineweaver-Burk transformation of the inhibition data indicates that inhibition by both psoralen and isopsoralen is non-competitive for MAO-A. The Ki values were calculated to be 14.0 microM for psoralen and 6.5 microM for isopsoralen. On the other hand, inhibition by both psoralen and isopsoralen is competitive for MAO-B. The Ki values were calculated to be 58.1 microM for psoralen and 10.8 microM for isopsoralen. These inhibitory actions of psoralen and isopsoralen on rat brain mitochondrial MAO activities are discussed in relation to their toxicities and their potential applications to treat affective disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169165     DOI: 10.1034/j.1600-0773.2001.d01-86.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  9 in total

1.  Optimization and mechanism of postponing aging of polysaccharides from Chinese herbal medicine formula.

Authors:  Xiuying Pu; Amiao Luo; Hui Su; Kaili Zhang; Changyi Tian; Bo Chen; Pengdi Chai; Xiaoyu Xia
Journal:  Toxicol Res (Camb)       Date:  2020-05-11       Impact factor: 3.524

2.  High throughput screening to identify natural human monoamine oxidase B inhibitors.

Authors:  E Mazzio; S Deiab; K Park; K F A Soliman
Journal:  Phytother Res       Date:  2012-08-08       Impact factor: 5.878

3.  In vitro acetylcholinesterase inhibition by psoralen using molecular docking and enzymatic studies.

Authors:  Gauresh Somani; Chinmay Kulkarni; Prashant Shinde; Rupesh Shelke; Kirti Laddha; Sadhana Sathaye
Journal:  J Pharm Bioallied Sci       Date:  2015 Jan-Mar

4.  The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.

Authors:  Najla O Zarmouh; Suresh K Eyunni; Karam F A Soliman
Journal:  BMC Complement Altern Med       Date:  2017-01-10       Impact factor: 3.659

5.  The changes of hepatic bile acid synthesis and transport and bile acids profiles in isopsoralen-induced liver injury C57BL/6J mice.

Authors:  Wei-Jie Men; Zhao-Jun Meng; Qin Wang; Meng-Ying Chen; Yu-Xia Zhai; Hong Shi; An-Hong Wang; Kun Zhou
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

6.  Isopsoralen Induces Differentiation of Prechondrogenic ATDC5 Cells via Activation of MAP Kinases and BMP-2 Signaling Pathways.

Authors:  Liang Li; Jae Soon Eun; Manoj Nepal; Jae-Ha Ryu; Hyoung Kwon Cho; Bo-Yun Choi; Yunjo Soh
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

7.  Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors.

Authors:  Najla O Zarmouh; Samia S Messeha; Faisel M Elshami; Karam F A Soliman
Journal:  European J Med Plants       Date:  2016-05-27

8.  Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor.

Authors:  Najla O Zarmouh; Samia S Messeha; Faisel M Elshami; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-28       Impact factor: 2.629

9.  Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent

Authors:  María Del Pilar Olaya; Nadezdha Esperanza Vergel; José Luis López; María Dolores Viña; Mario Francisco Guerrero
Journal:  Biomedica       Date:  2019-09-01       Impact factor: 0.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.